BASF stock forecast: 2026 Guidance Misses Consensus

BASF is a Germany-based chemicals group whose shares came under pressure after the company’s 2026 EBITDA guidance fell below analyst consensus in its late-February results. Past performance is not a reliable indicator of future results. Explore third-party BAS price targets and technical analysis.

By Dan Mitchellan hour ago

BASF company sign displayed in front of a modern office building — Photo: Shutterstock

BASF SE (BAS) is trading at €48.22 in early European trading at 10:13am UTC on 17 March 2026, within a session range of €47.50-€48.42, as reported via the Capital.com quote feed. Past performance is not a reliable indicator of future results.

Sentiment on the shares remains cautious following BASF's late-February full-year results, in which the company guided 2026 EBITDA before special items at €6.2-€7.0 billion - a range whose upper bound fell short of the average analyst consensus of €7.02 billion (Reuters, 17 February 2026). BASF cited a weaker US dollar as a headwind and flagged a potential €200 million currency impact in Q1 (Yahoo Finance, 27 February 2026).

Looking at macroeconomic factors, the DAX index was quoted near 23,582 on 17 March 2026, with the index trading below mid-February highs above 24,200, while the ECB's euro reference rate stood at USD 1.1478 on 16 March 2026, reflecting continued euro strength that may weigh on BASF's US-dollar-denominated revenues (Trading Economics, 17 March 2026). BASF also raised its cost-savings target to €2.3 billion by end-2026 from a prior goal of €2.1 billion, as the company confirmed in its official annual results release (BASF, 27 February 2026).

BASF stock forecast 2026–2030: Third-party price targets

As of 17 March 2026, third-party BASF stock predictions reflect sharply divergent views heading into mid-March 2026, shaped by the company's cautious 2026 EBITDA guidance, its accelerated cost-reduction programme, and the uncertain pace of a chemicals-sector recovery.

J.P. Morgan (underweight, bear case)

J.P. Morgan analyst Chetan Udeshi reiterates an Underweight rating and a €36 price target, the lowest published target among covering brokers. Udeshi argues that BASF's share price has become disconnected from underlying fundamentals, as quarterly results and the 2026 guidance range do not provide evidence of an imminent earnings recovery (The Globe and Mail, 5 March 2026).

UBS (neutral, trimmed target)

UBS analyst Geoff Haire keeps a Neutral rating while trimming the price target to €47 from €48. Haire cites continued caution on near-term earnings momentum amid persistent oversupply in core chemicals end markets, with the modest target reduction reflecting post-results estimate revisions (MarketScreener, 4 March 2026).

BASF Investor Relations (company consensus snapshot)

BASF's own analyst-estimates page reports a mean consensus BAS stock forecast of €49.52 across covering analysts, with a high of €62 and a low of €36. The wide spread reflects diverging assumptions on the timing of a chemicals-cycle upturn and the delivery of BASF's targeted €2.3 billion in annual cost savings (BASF Investor Relations, 12 March 2026).

Goldman Sachs (buy, top-of-range target)

Goldman Sachs analyst Georgina Fraser reaffirms a Buy rating and a €62 price target, the highest target among recently publishing brokers. Fraser retains a constructive stance, citing BASF's structural cost levers and longer-dated earnings recovery potential, with the group's diversified platform offering exposure to a possible upturn in downstream industrial demand (MarketScreener, 4 March 2026).

Across these sources, 12-month BASF stock predictions span €36 to €62, with the BASF-compiled mean near €49.52, reflecting a clear split between bears focused on near-term earnings detachment and bulls focused on restructuring delivery and a future chemicals-cycle recovery.

Predictions and third-party forecasts are inherently uncertain, as they cannot fully account for unexpected market developments. Past performance is not a reliable indicator of future results.

BAS stock price: Technical overview

The BAS stock price trades at €48.22 as of 10:13am UTC on 17 March 2026, holding above a broadly supportive moving-average cluster where the 20/50/100/200-day SMAs sit at approximately €48/€47/€46/€45. The 20-over-50 alignment remains intact across both the SMA and EMA families, keeping the near-term trend constructive, though the 30-day SMA at €48.52 and the hull moving average at €49.12 signal mild near-term resistance just above current levels.

Momentum is upper-neutral: the 14-day RSI reads 54.85, consistent with a market that is recovering but not yet stretched, while the MACD level at -0.06 and the momentum indicator at +3 both carry buy signals, suggesting that upside pressure is building, although it remains tentative.

On the topside, the classic R1 pivot at €52.37 is the first meaningful reference; a convincing daily close above that level would put R2 at €56.05 into focus. The Ichimoku base line at €48.29 sits just above the current last price and may act as an interim cap before any move towards R1.

On pullbacks, the classic pivot point at €49.01 provides initial support, followed by the 50-day SMA shelf near €47. A move below the 100-day SMA near €46 would blunt the short-term trend and could expose S1 at €45.33 (TradingView, 17 March 2026).

This is technical analysis for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any instrument.

BASF share price history (2024–2026)

BAS’s stock price traded around €49.21 in mid-March 2024, drifting lower into year-end to close 2024 at €42.58.

The stock climbed sharply through early 2025, reaching a two-year intraday high of €54.85 on 10 March 2025, lifted by broader DAX strength and optimism around BASF's cost-cutting programme. That rally proved short-lived. A sell-off through late March and into April 2025, deepened by global trade uncertainty, dragged the shares to a two-year intraday low of €37.52 on 7 April 2025 - a fall of roughly 32% from the March peak in under a month.

BAS recovered steadily through the second half of 2025, closing the year at €44.61 on 30 December. A second leg higher followed in early 2026, with the stock reaching an intraday high of €52.76 on 12 February 2026 before BASF's full-year results prompted a fresh retreat; the company guided 2026 EBITDA below analyst consensus, and shares slipped back through the €48-€49 range.

BAS closed at €48.33 on 17 March 2026, approximately 7.8% up year to date from the 2 January 2026 open of €44.84, but around 8.2% lower year on year compared with €52.65 on 17 March 2025.

Past performance is not a reliable indicator of future results.

BASF (BAS): Capital.com analyst view

BASF's share price has experienced a turbulent two years, swinging from a two-year high near €54.85 in March 2025 to a two-year low around €37.52 in April 2025, before recovering to the €48 area by mid-March 2026. The late-2025 and early-2026 rebound reflects improving sentiment around BASF's accelerated cost-reduction programme, with the company targeting €2.3 billion in annual savings by end-2026. However, the sharp post-results retreat from February 2026 highs above €52 illustrates the tension between restructuring optimism and the reality of a 2026 EBITDA guidance range that fell short of analyst consensus - a reminder that execution risk remains material.

Looking at the broader picture, persistent euro strength poses a headwind for BASF's dollar-denominated revenues, while weak demand from China and sluggish European industrial output continue to weigh on core chemicals margins. On the other hand, any acceleration in European industrial activity, a softer euro, or faster-than-expected delivery of cost savings could provide support. The wide spread of analyst price targets - from €36 to €62 - reflects uncertainty about the pace and durability of any recovery.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Past performance is not a reliable indicator of future results.

Capital.com’s client sentiment for BASF CFDs

As of 17 March 2026, Capital.com client positioning in BASF CFDs shows 96.2% buyers versus 3.8% sellers, putting buyers ahead by 92.4 percentage points and placing sentiment firmly in a one-sided long position. This snapshot reflects open positions on Capital.com and can change.

Summary – BASF 2026

BAS trades at €48.22 as of 10:13am UTC on 17 March 2026, up roughly 7.8% year to date but around 8.2% lower year on year.
The classic pivot point at €49.01 acts as initial resistance, with R1 at €52.37 the next topside reference; key support sits near the 50-day SMA around €47.
Key drivers include BASF's cautious 2026 EBITDA guidance range of €6.2-€7.0 billion, which fell short of analyst consensus following its full-year results in late February 2026.
Euro strength versus the US dollar is flagged as a potential headwind, with BASF citing a possible €200 million currency impact in Q1 2026 alone.
BASF raised its cost-savings target to €2.3 billion by end-2026, though analysts remain divided on the pace and credibility of delivery amid weak European industrial demand.

Past performance is not a reliable indicator of future results.

FAQ

Who owns the most BASF stock?

BASF’s shareholder base is widely distributed, with no single controlling owner. Based on the article’s themes, the company is typically viewed as broadly held by institutional investors, asset managers and other market participants rather than dominated by one majority shareholder. That matters because a dispersed ownership structure can support liquidity, but it does not remove share price risk. Investors should check BASF’s latest shareholder disclosures and annual report for the most up-to-date ownership breakdown.

What is the 5 year BASF share price forecast?

A five-year BAS stock forecast is inherently uncertain because it depends on several variables that can change over time, including chemical demand, industrial activity, currency moves, energy costs and the company’s ability to deliver cost savings. The article highlights a wide spread in shorter-term analyst targets, which underlines that uncertainty. Longer-term forecasts should therefore be treated as scenarios rather than reliable predictions, especially in a cyclical sector such as chemicals.

Is BASF a good stock to buy?

Whether BASF is a good stock to buy depends on an individual’s objectives, time horizon and tolerance for risk. The article presents both supportive and cautious factors: cost-saving measures and a potential industry recovery on one side, and softer earnings guidance, currency pressure and weak industrial demand on the other. Because those factors can pull the share price in different directions, the stock may suit some market participants more than others. This is not investment advice.

Could BASF stock go up or down?

BASF stock could move in either direction, depending on how company-specific and external factors develop. As outlined in the article, potential support could come from improved industrial demand, delivery of cost reductions or a more favourable currency backdrop. Downside risks may include weaker chemicals demand, margin pressure, slower restructuring progress or continued euro strength against the US dollar. Technical levels may help traders frame scenarios, but they do not guarantee future price direction.

Should I invest in BASF stock?

Deciding whether to invest in BASF is a personal decision and should reflect your financial situation, goals and appetite for risk. The article does not suggest that BASF is suitable or unsuitable for any particular reader. Instead, it outlines a balanced picture of possible opportunities and risks, including earnings uncertainty and restructuring potential. Anyone considering exposure should review the company’s fundamentals, market conditions and risk disclosures carefully before making a decision.

Can I trade BASF CFDs on Capital.com?

Yes, you can trade BASF CFDs on Capital.com. Trading share CFDs lets you speculate on price movements without owning the underlying asset and to take long or short positions. However, contracts for difference (CFDs) are traded on margin, and leverage amplifies both profits and losses. You should ensure you understand how CFD trading works, assess your risk tolerance, and recognise that losses can occur quickly.